| Address: | 30 Murray Farm Rd, Carlingford NSW 2118, Australia |
|---|---|
| Postal code: | 2118 |
| Phone: | 0405 276 959 |
| Monday: | 8:00 AM – 7:00 PM |
|---|---|
| Tuesday: | 8:00 AM – 7:00 PM |
| Wednesday: | 8:00 AM – 7:00 PM |
| Thursday: | 8:00 AM – 7:00 PM |
| Friday: | 8:00 AM – 7:00 PM |
| Saturday: | 8:00 AM – 7:00 PM |
| Sunday: | 8:00 AM – 7:00 PM |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about HB Biotech Australia, use the form below and your opinion, advice or comment will appear in this space.
HB Biotech Australia is located in The Hills Shire of New South Wales state. On the street of Murray Farm Road and street number is 30. On the street of Murray Farm Road and street number is 30. To communicate or ask something with the place, the Phone number is 0405 276 959.
The company's Board and its executives have deep and broad experience in both managing investments and providing family office and other administrative support to both high net worth families, individuals, and the not-for-profit sector.
公司拥有尖端的护肤品研究中心，先进的研发设备和优秀的研发团队，以纯天然植物精华为主，运用现代生物科技等前. 电话： 0405 276 959. 地区： 北西区 (Carlingford, Eastwood) 地址： sydney. 悉尼麦考瑞回国礼品递送，Macquarie大学附近，电话：0431768152，微信：bj60285 ...
回网站首页, 更多更新优惠 ...
Geistlich Pharma Australia Pty Ltd. The Zenith - Tower A, Level 21 821 Pacific Highway Chatswood NSW 2067 - Australia
Dr Michelle Miller, BSc, MSc, PhD GCertAppFin (Finsia)Chief Executive Officer and Managing Director. Dr Miller has worked for over 25 years in the bioscience industry, with extensive experience in commercial drug development. She completed her PhD in the Faculty of Medicine at Sydney University investigating molecular models of cancer development.
ABOUT US. Our vision is to make waste to landfill a thing of the past! We pride ourselves on our ability to deliver sustainable, reliable, quality and affordable cleaning and waste management services to clients throughout Australia. In doing so, we are limiting waste going to landfill and toxic chemicals being used throughout Australia.
Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company. The clinical stage drug candidate is Veyonda® (previously known as NOX-66). Veyonda® is a first-in-class, dual-acting cytotoxic and immuno-oncology drug candidate designed to enhance the effectiveness and safety of both chemotherapy and radiotherapy.
Marketing of infant formulas to health care professionals, developing sales and presentation materials for the sales force, product management (forecasting, developing product labels, managing marketing budget), developing education materials and programs for health care professionals on infant nutrition and other aspects of infant care